title: Respiratory syncytial virus infects the Bonnet monkey, Macaca radiata.
abstract: The Bonnet monkey model of respiratory syncytial virus (RSV) infection may be a useful nonhuman primate model for studying RSV disease in humans because Bonnet monkeys can predictably be infected to obtain an orderly sequence of morphologic, cytologic, virologic, serologic, and inflammatory changes related to time of infection. Young feral Bonnet monkeys, Macaca radiata, were infected endotracheally with 10(6) plaque-forming units (pfu) of the Long strain of RSV. RSV was recovered from the animals' lungs at necropsy on days 3, 5, and 7 with the highest viral titer obtained on day 3 (1.1 and 5.2 x 10(3) pfu/g of tissue in the upper and lower lobes, respectively). RSV antigen and F protein mRNA were detected 3-5 days after infection in alveolar macrophages and in the epithelium of bronchi, terminal bronchioles, and alveoli. Histologic analysis of RSV-infected lungs at necropsy revealed progressive bronchiolar mucosal and submucosal inflammation, periarterial mononuclear interstitial inflammation, and focal alveolitis, with a maximal response at 7 days after infection. Cell counts in bronchoalveolar lavage (BAL) increased with time with neutrophils and macrophages predominating on day 3 (6.47 and 5.85 x 10(5)/mm3, respectively) and lymphocytes predominating on day 9 (4.18 x 10(5)/mm3). Serum-neutralizing antibody appeared on day 5 and IgG antibody to RSV was detected on day 9. This sequence of morphologic, cytologic, virologic, serologic, and inflammatory change following RSV infection creates a useful model in the study of experimentally induced RSV disease with a potential for testing future vaccine-induced alterations in RSV disease response.
authors.affiliation: Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Simoes
authors.forename: A R
authors.initials: AR
authors.lastname: Hayward
authors.forename: E M
authors.initials: EM
authors.lastname: Ponnuraj
authors.forename: J P
authors.initials: JP
authors.lastname: Straumanis
authors.forename: K R
authors.initials: KR
authors.lastname: Stenmark
authors.forename: H L
authors.initials: HL
authors.lastname: Wilson
authors.forename: P G
authors.initials: PG
authors.lastname: Babu
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D000956:Antigens, Viral / Q000032:analysis; D001988:Bronchiolitis / Q000276:immunology / Q000473:pathology* / Q000821:virology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000821:virology; D002452:Cell Count; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D017403:In Situ Hybridization; D008255:Macaca radiata / Q000821:virology*; D016676:Macrophages, Alveolar / Q000473:pathology / Q000821:virology; D011650:Pulmonary Alveoli / Q000473:pathology / Q000821:virology; D012333:RNA, Messenger / Q000096:biosynthesis; D012367:RNA, Viral / Q000032:analysis; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000473:pathology* / Q000821:virology; D012136:Respiratory Syncytial Viruses / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity; D014779:Virus Replication
chemical_list: D000956:Antigens, Viral; D012333:RNA, Messenger; D012367:RNA, Viral